Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Kyuan Pharmaceutical, officially known as Beijing Kyuan Xinhai Pharmaceutical Co., Ltd., is a prominent pharmaceutical service provider and a core subsidiary of China Resources Pharmaceutical Group. The company specializes in the import, distribution, and marketing of high-end pharmaceutical products, with a particular strength in vaccine distribution and cold chain logistics. It serves as a critical bridge for multinational pharmaceutical companies seeking to enter the Chinese market, providing comprehensive supply chain solutions and market access services. Kyuan operates extensive logistics networks across China and maintains partnerships with numerous global healthcare leaders such as Pfizer, Roche, and MSD. The company is recognized as one of the top pharmaceutical importers in China, playing a vital role in the delivery of innovative therapies and vaccines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Kyuan Pharmaceutical.